Archivo diario: marzo 19, 2021

Institute of Neurology and Neurosurgery of Cuba will initiate studies on the effects of Covid-19 in recovered patients

The Neurology and Neurosurgery Institute of Cuba will start a study, in the next few days, on the neurological manifestations in patients who recovered from Covid-19.

According to the president of the Scientific Council of Clinical Neurophysiology, Dr. Joel Gutierrez, the research will assess the percentage of patients who suffered from this disease in which this type of conditions appears, its intensity and the possible persistence of effects.

Sigue leyendo
Categorías: Ciencia, COVID-19, Cuba, Especiales | Etiquetas: , , , | Deja un comentario

Measures have been taken in Cuba to protect women from the Covid-19 pandemic.

Cuba took labor, salary, security and social assistance measures to protect the entire population, especially women, in the face of the Covid-19 pandemic, Cuba’s Alternate Permanent Representative to the United Nations Ana Silvia Rodriguez said on Thursday at the UN.

Rodriguez provided details on this topic during the interactive dialogue ‘Building back better: Women’s participation and leadership in COVID-19 response and recovery.’

Sigue leyendo
Categorías: COVID-19, Cuba, Salud | Etiquetas: , , , , , , , , | Deja un comentario

Cuba and a unique story on terrorism

On March 19, 1998, Prensa Latina reported an unusual event from Geneva: Cuba, the country that the United States had been describing since 1982 as a sponsor of terrorism, was acknowledged as a victim of this type of actions.
A report presented at the 54th session of the United Nations Human Rights Commission stated that the attacks on tourist facilities in Havana in 1997 were perpetrated by people funded from the United States.

Sigue leyendo
Categorías: Cuba | Etiquetas: , , , | Deja un comentario

Inicia Fase III de ensayo clínico de Abdala, candidato vacunal cubano contra la Covid-19

La Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos de la República de Cuba, CECMED aprobó en el día de hoy la autorización para realizar el Ensayo Clínico Fase III del Candidato Vacunal Abdala.

Esta aprobación se fundamenta en los resultados de seguridad demostrados en los estudios Fase I y II.

Sigue leyendo
Categorías: Ciencia, COVID-19, Cuba | Etiquetas: , , , | Deja un comentario

A %d blogueros les gusta esto: